PainChek General Discussion, page-6834

Yes, that is a strong possibility. Especially if the constant monitoring research with Philips or nVisio is a success. Such pain killer manufacturer could well use Painchek to monitor and time the efficacy of the pain killer. May even help them decide on the most efficient dose and all that. So yes, certainly lots of potential. But I believe that would be years away down the road.

For now, I like the fact that the company has a business model, revenue model and strategy for the progress of the company. It is not all over the place. And very down to earth too without much fanfare. In fact, as a shareholder of this speculative company, I feel like I am holding a great blue chip. Steady as she goes